Effect of genetic variants in KCNJ11, ABCC8, PPARG and HNF4A loci on the susceptibility of type 2 diabetes in Chinese Han population

Chinese Medical Journal

Volumn 122, Issue 20, 2009, Pages 2477-2482

  Wang, Fang ^a   Han, Xue Yao ^a   Ren, Qian ^a   Zhang, Xiu Ying ^a   Han, Ling Chuan ^a   Luo, Ying Ying ^a   Zhou, Xiang Hai ^a   Ji, Li Nong ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

ABCC8; HNF4A; KCNJ11; PPARG; Type 2 diabetes

Indexed keywords

CELL PROTEIN; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; INSULIN; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN ABCC8; UNCLASSIFIED DRUG;

ADULT; AGE; ANALYTICAL EQUIPMENT; ARTICLE; BODY MASS; CASE CONTROL STUDY; CHINA; CHINESE; CONTROLLED STUDY; FEMALE; GENE INTERACTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HUMAN; INSULIN RELEASE; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; RISK ASSESSMENT; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ATP-BINDING CASSETTE TRANSPORTERS; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEPATOCYTE NUCLEAR FACTOR 4; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; POTASSIUM CHANNELS, INWARDLY RECTIFYING; PPAR GAMMA; RECEPTORS, DRUG;

EID: 70350702970     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.20.015     Document Type: Article

References (33)

1. Barroso I. Genetics of Type 2 diabetes. Diabet Med 2005; 22: 517-535.
2. Thomas PM, Cote GJ, Wohllk N, Haddad B, Mathew PM, Rabl W, et al. Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science 1995; 268: 426-429.
3. Inagaki N, Gonoi T, Clement JP, Namba N, Inazawa J, Gonzalez G, et al. Reconstitution of IKATP: an inward rectifier subunit plus the sulfonylurea receptor. Science 1995; 270: 1166-1170.
4. Sharma N, Crane A, Gonzalez G, Bryan J, Aguilar-Bryan L. Familial hyperinsulinism and pancreatic beta-cell ATP-sensitive potassium channels. Kidney Int 2000; 57: 803-808. (Pubitemid 30434769)
5. Gloyn AL, Pearson ER, Antcliff JF, Proks P, Bruining GJ, Slingerland AS, et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 2004; 350: 1838-1849. (Pubitemid 38917250)
6. Yokoi N, Kanamori M, Horikawa Y, Takeda J, Sanke T, Furuta H, et al. Association studies of variants in the genes involved in pancreatic beta-cell function in type 2 diabetes in Japanese subjects. Diabetes 2006; 55: 2379-2386. (Pubitemid 44743638)
7. Doi Y, Kubo M, Ninomiya T, Yonemoto K, Iwase M, Arima H, et al. Impact of Kir6.2 E23K polymorphism on the development of type 2 diabetes in a general Japanese population: The Hisayama Study. Diabetes 2007; 56: 2829-2833. (Pubitemid 350044927)
8. Saxena R, Voight BF, Lyssenko V, Burtt NP, de BP, Chen H, et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007; 316: 1331-1336. (Pubitemid 46871653)
9. Zeggini E, Weedon MN, Lindgren CM, Frayling TM, Elliott KS, Lango H, et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 2007; 316: 1336-1341. (Pubitemid 46871654)
10. Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, Duren WL, et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007; 316: 1341-1345. (Pubitemid 46871655)
11. Deeb SS, Fajas L, Nemoto M, Pihlajamaki J, Mykkanen L, Kuusisto J, et al. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 1998; 20: 284-287. (Pubitemid 28507675)
12. Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J, et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 2000; 26: 76-80. (Pubitemid 30692861)
13. Ji L, Malecki M, Warram JH, Yang Y, Rich SS, Krolewski AS. New susceptibility locus for NIDDM is localized to human chromosome 20q. Diabetes 1997; 46: 876-881. (Pubitemid 27188267)
14. Luo TH, Zhao Y, Li G, Yuan WT, Zhao JJ, Chen JL, et al. A genome-wide search for type II diabetes susceptibility genes in Chinese Hans. Diabetologia 2001; 44: 501-506. (Pubitemid 32324362)
15. Yamagata K, Furuta H, Oda N, Kaisaki PJ, Menzel S, Cox NJ, et al. Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1). Nature 1996; 384: 458-460. (Pubitemid 26414661)
16. Love-Gregory LD, Wasson J, Ma J, Jin CH, Glaser B, Suarez BK, et al. A common polymorphism in the upstream promoter region of the hepatocyte nuclear factor-4 alpha gene on chromosome 20q is associated with type 2 diabetes and appears to contribute to the evidence for linkage in an Ashkenazi Jewish population. Diabetes 2004; 53: 1134-1140. (Pubitemid 38436629)
17. Hara K, Horikoshi M, Kitazato H, Ito C, Noda M, Ohashi J, et al. Hepatocyte nuclear factor-4alpha P2 promoter haplotypes are associated with type 2 diabetes in the Japanese population. Diabetes 2006; 55: 1260-1264. (Pubitemid 44195362)
18. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539-553.
19. Han XY, Ji LN. Contribution of MODY2 gene to the pathogenesis of Chinese early onset familial type 2 diabetes. Beijing Da Xue Xue Bao 2005; 37: 591-594.
20. Han XY, Liu CY, Ji LN. Contribution of MODY6 gene in the pathogenesis of familial type 2 diabetes in Chinese population. Natl Med J China (Chin) 2005; 85: 2463-2467. (Pubitemid 41388220)
21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
22. Qi L, van DR, Asselbergs FW, Hu FB. Gene-gene interactions between HNF4A and KCNJ11 in predicting Type 2 diabetes in women. Diabet Med 2007; 24: 1187-1191.
23. Cho YM, Ritchie MD, Moore JH, Park JY, Lee KU, Shin HD, et al. Multifactor-dimensionality reduction shows a two-locus interaction associated with Type 2 diabetes mellitus. Diabetologia 2004; 47: 549-554.
24. Gu D, Reynolds K, Duan X, Xin X, Chen J, Wu X, et al. Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). Diabetologia 2003; 46: 1190-1198. (Pubitemid 37214976)
25. Schwanstecher C, Meyer U, Schwanstecher M. K(IR)6.2 polymorphism predisposes to type 2 diabetes by inducing overactivity of pancreatic beta-cell ATP-sensitive K(+) channels. Diabetes 2002; 51: 875-879.
26. Nielsen EM, Hansen L, Carstensen B, Echwald SM, Drivsholm T, Glumer C, et al. The E23K variant of Kir6.2 associates with impaired post-OGTT serum insulin response and increased risk of type 2 diabetes. Diabetes 2003; 52: 573-577. (Pubitemid 36173219)
27. Inoue H, Ferrer J, Welling CM, Elbein SC, Hoffman M, Mayorga R, et al. Sequence variants in the sulfonylurea receptor (SUR) gene are associated with NIDDM in Caucasians. Diabetes 1996; 45: 825-831. (Pubitemid 26166780)
28. Mori H, Ikegami H, Kawaguchi Y, Seino S, Yokoi N, Takeda J, et al. The Pro12 ->Ala substitution in PPAR-gamma is associated with resistance to development of diabetes in the general population: possible involvement in impairment of insulin secretion in individuals with type 2 diabetes. Diabetes 2001; 50: 891-894. (Pubitemid 32242650)
29. Frederiksen L, Brodbaek K, Fenger M, Jorgensen T, Borch-Johnsen K, Madsbad S, et al. Comment: studies of the Pro12Ala polymorphism of the PPAR-gamma gene in the Danish MONICA cohort: homozygosity of the Ala allele confers a decreased risk of the insulin resistance syndrome. J Clin Endocrinol Metab 2002; 87: 3989-3992. (Pubitemid 34879559)
30. Radha V, Vimaleswaran KS, Babu HN, Abate N, Chandalia M, Satija P, et al. Role of genetic polymorphism peroxisome proliferator-activated receptor-gamma2 Pro12Ala on ethnic susceptibility to diabetes in South-Asian and Caucasian subjects: Evidence for heterogeneity. Diabetes Care 2006; 29: 1046-1051. (Pubitemid 44115242)
31. Moller AM, Urhammer SA, Dalgaard LT, Reneland R, Berglund L, Hansen T, et al. Studies of the genetic variability of the coding region of the hepatocyte nuclear factor-4alpha in Caucasians with maturity onset NIDDM. Diabetologia 1997; 40: 980-983. (Pubitemid 27316582)
32. Weedon MN, Owen KR, Shields B, Hitman G, Walker M, McCarthy MI, et al. Common variants of the hepatocyte nuclear factor-4alpha P2 promoter are associated with type 2 diabetes in the U.K. population. Diabetes 2004; 53: 3002-3006. (Pubitemid 39425928)
33. Black MH, Fingerlin TE, Allayee H, Zhang W, Xiang AH, Trigo E, et al. Evidence of interaction between PPARG2 and HNF4A contributing to variation in insulin sensitivity in Mexican Americans. Diabetes 2008; 57: 1048-1056.